Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Georg Greiner, Bettina Sprinzl, Aleksandra Górska, et al.
Blood (2020) Vol. 137, Iss. 2, pp. 238-247
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
Peter Valent, Cem Akin, Karin Hartmann, et al.
HemaSphere (2021) Vol. 5, Iss. 11, pp. e646-e646
Open Access | Times Cited: 204
Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management
Animesh Pardanani
American Journal of Hematology (2021) Vol. 96, Iss. 4, pp. 508-525
Open Access | Times Cited: 142
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
Kimberly Risma, Kathryn M. Edwards, Donna S. Hummell, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 147, Iss. 6, pp. 2075-2082.e2
Open Access | Times Cited: 132
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Joakim S. Dahlin, Marcus Maurer, Dean D. Metcalfe, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 83-99
Open Access | Times Cited: 111
Anaphylaxis: A 2023 practice parameter update
David B.K. Golden, Julie Wang, Susan Waserman, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 2, pp. 124-176
Open Access | Times Cited: 87
Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Animesh Pardanani
American Journal of Hematology (2023) Vol. 98, Iss. 7, pp. 1097-1116
Open Access | Times Cited: 57
Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives
Vanitha Sampath, Grace Rabinowitz, Mihir Shah, et al.
Allergy (2021) Vol. 76, Iss. 6, pp. 1640-1660
Open Access | Times Cited: 102
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine
Peter Valent, Cem Akin, Bogusław Nedoszytko, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9030-9030
Open Access | Times Cited: 70
Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis
Joana Vitte, Vito Sabato, Charles Tacquard, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 8, pp. 2994-3005
Open Access | Times Cited: 61
Hereditary alpha tryptasemia is not associated with specific clinical phenotypes
Madeleine B. Chollet, Cem Akin
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 2, pp. 728-735.e2
Closed Access | Times Cited: 59
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1941-1950
Open Access | Times Cited: 57
Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis
Allyson Mateja, Qinlu Wang, Jack Chovanec, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 1010-1017.e10
Open Access | Times Cited: 56
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice
Peter Valent, Karin Hartmann, Juliana Schwaab, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1999-2012.e6
Open Access | Times Cited: 47
New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy
Peter Valent, Cem Akin, Wolfgang R. Sperr, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 361-386
Open Access | Times Cited: 40
Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
International Archives of Allergy and Immunology (2022) Vol. 183, Iss. 7, pp. 693-705
Open Access | Times Cited: 39
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT
Peter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 10, pp. 3010-3020
Open Access | Times Cited: 26
Diagnosis and treatment of Hymenoptera venom allergy
Franziska Ruëff, Andrea Bauer, Sven Becker, et al.
Allergologie select (2023) Vol. 7, Iss. 1, pp. 154-190
Open Access | Times Cited: 25
Hereditary alpha-tryptasemia in 101 patients with mast cell activation–related symptomatology including anaphylaxis
Matthew P. Giannetti, Emily Weller, Concetta Bormans, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 126, Iss. 6, pp. 655-660
Closed Access | Times Cited: 52
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 11, pp. 3918-3928
Open Access | Times Cited: 50
The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia
Kathleen Luskin, Andrew A. White, Jonathan J. Lyons
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 6, pp. 2235-2242
Closed Access | Times Cited: 46
Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone
Julij Šelb, Matija Rijavec, Renato Eržen, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 2, pp. 621-626.e7
Open Access | Times Cited: 41
The international consensus classification of mastocytosis and related entities
Roos J. Leguit, Sa A. Wang, Tracy I. George, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 99-112
Closed Access | Times Cited: 31
Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System
Aubri M. Waters, Hyun J Park, Andrew L. Weskamp, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 9, pp. 2424-2435.e5
Open Access | Times Cited: 30
Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions
Jonathan J. Lyons, Georg Greiner, Gregor Hoermann, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1964-1973
Open Access | Times Cited: 28
Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms
Jack Chovanec, Ilker Tunc, Jason Hughes, et al.
Blood Advances (2022) Vol. 7, Iss. 9, pp. 1796-1810
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top